ArriVent BioPharma Inc. C... (AVBP)
18.43
-0.20 (-1.07%)
At close: Apr 16, 2025, 11:39 AM
ArriVent BioPharma Common Stock Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
38
Upside
106.24
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| B. Riley Securities | Buy | Initiates | 37 | 100.81% | Mar 20, 2025 | |
| Guggenheim | Buy | Initiates | 45 | 144.23% | Mar 10, 2025 | |
| HC Wainwright & Co. | Buy | Reiterates | 39 39 | 111.67% | Mar 7, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.